GLPwatch
Trials (2083)
Page 33 of 35.
- Efficacy and Safety of Soliqua Versus Lantus in Ethnically/Racially Diverse Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic Agents
- Semaglutide to Reduce Atrial Fibrillation Burden
- Effects of Exenatide on Glycemic Control and Weight in Continuous Subcutaneous Insulin Infusion (CSII) Type 2 Treated Patients With Type 2 Diabetes
- Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes
- Pharmacogenetics of Response to GLP1R Agonists
- The Effects of Exenatide (Byetta ) on Energy Expenditure and Weight Loss in Nondiabetic Obese Subjects
- Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Insulin Glargine Alone on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan
- A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
- Impact of Exenatide on Cardiovascular Exercise Performance in Type 2 Diabetes
- Mechanisms of Semaglutide Therapy in Heart Failure Patients
- Weight Loss in Adults Using Semaglutide (Real-world Study)
- Effect of Soliqua 100/33 on Time in Range From Continuous Glucose Monitoring in Insulin-naive Patients With Very Uncontrolled Type 2 Diabetes Mellitus
- Effects on Re-endothelialisation With Bydureon Treatment in Type 2 Diabetes Subjects
- Bariatric Surgery vs. Semaglutide vs. Tirzepatide
- A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
- A Study to Test Whether Survodutide Improves How the Body Uses Energy and Breaks Down Fat in People With Obesity
- The Efficacy and Safety of Insulin Degludec/Liraglutide Combination (IDegLira) in Patients With Type 2 Diabetes
- Effect of Liraglutide on Automated Closed-loop Glucose Control in Type 1 Diabetes
- Study of the Safety and Tolerability of Switching to ITCA 650 in Patients With Type 2 Diabetes Receiving Liraglutide
- Prevention of Progression of Prediabetes, Obesity and CV Risk
- A Study to Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 Diabetes
- GLP1-imaging Before and After Bariatric Surgery
- a Study of JY09 in Chinese Healthy Subjects
- Real-world Canadian Retrospective Study Evaluating Longitudinal Semaglutide Use on Cardio-Kidney-Metabolic Outcomes
- Lixisenatide for Restoration of Insulin Release in Subjects With Diabetes Mellitus Type 2
- A Study of HM11260C in Healthy Male Subject
- A Study to Examine the Effects of Exenatide Once-Weekly Injection on Glucose Control and Safety in Asian Subjects
- A Study of LY3437943 in Healthy Participants and Participants With Impaired Renal Function
- The Effectivity and Safety Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus
- Effect of Semaglutide and Tirzepatide Combined With Exercise in Obesity
- Investigation of the Relationship Between Peripheral and Central Metabolic Changes Induced by GLP-1 Agonists
- A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
- Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis
- The Efficacy, Mechanism & Safety of Sodium Glucose Co-Transporter-2 Inhibitor & Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Kidney Transplant Recipients
- Research Study to Look at How Well Cagrilintide Together With Semaglutide Works in People With Type 2 Diabetes
- Effect of Liraglutide for Weight Management in Paediatric Subjects With Prader-Willi Syndrome
- Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder
- Liraglutide Efficacy and Action in Non-Alcoholic Steatohepatitis
- GLP-1s to Enhance Lasting Optimal Weight
- 24-week Study Comparing Lixisenatide to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 Years
- A Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes.
- Use of a GLP-1R Agonist to Treat Opioid Use Disorder
- The Role of Glucagon-Like Peptide-1 Receptor Agonists in Coronary Artery Diseases and Their Potential Mechanisms
- LEAN Mass Preservation With Resistance Exercise and Protein During Semaglutide/Tirzepatide Therapy
- 2024 Tirzepatide-Bariatric Surgery
- A Research Study of How NNC0174-0833 Taken With Semaglutide Works in People Who Are Overweight or Obese
- Investigation of Efficacy and Safety of Three Dose Levels of Subcutaneous Semaglutide Once Daily Versus Placebo in Subjects With Non-alcoholic Steatohepatitis.
- GLP-1 Response and Effect in Individuals With Obesity Causing Genetic Mutations
- Efficacy and Safety of Oral Semaglutide Using a Flexible Dose Adjustment Based on Clinical Evaluation Versus Sitagliptin in Subjects With Type 2 Diabetes Mellitus.
- Semaglutide Anti-Atherosclerotic Mechanisms of Action Study in Type 2 Diabetes Patients
- A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly Versus Sitagliptin Once Daily in Japanese Subjects With Type 2 Diabetes
- Safety And Tolerability Of Lixisenatide In Monotherapy In Patients With Type 2 Diabetes
- Exenatide For Reducing the Reinforcing Effects of Cocaine
- Visualizing Beta Cells in Patients With a History of Gestational Diabetes
- Comparative Effectiveness of Tirzepatide vs Semaglutide in Participants With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction
- The Effect of Liraglutide on Endothelial Function in Subjects With Type 2 Diabetes Mellitus
- Comparison of Two Liraglutide Formulations in Healthy Subjects
- A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in The Netherlands, as Part of Local Clinical Practice (SURE NETHERLANDS)
- Study of the Effects of Intravenous Exenatide on Cardiac Repolarization
- Effect of Liraglutide in Combination With Sulfonylurea (SU) on Blood Glucose Control in Subjects With Type 2 Diabetes